Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report)’s share price shot up 8% during mid-day trading on Friday . The company traded as high as $0.57 and last traded at $0.57. 439,422 shares traded hands during trading, a decline of 82% from the average session volume of 2,497,775 shares. The stock had previously closed at $0.53.
Enveric Biosciences Stock Performance
The business’s 50 day moving average price is $0.61 and its two-hundred day moving average price is $0.85. The company has a market capitalization of $4.53 million, a price-to-earnings ratio of -0.09 and a beta of 0.74.
Enveric Biosciences (NASDAQ:ENVB – Get Free Report) last issued its quarterly earnings results on Tuesday, May 14th. The company reported ($0.61) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.61). On average, sell-side analysts expect that Enveric Biosciences, Inc. will post -1.98 earnings per share for the current year.
Institutional Trading of Enveric Biosciences
About Enveric Biosciences
Enveric Biosciences, Inc, a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health.
Recommended Stories
- Five stocks we like better than Enveric Biosciences
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Market Crash? No Problem for DoorDash Stock’s Impressive Earnings
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- 3 Healthcare Dividend Stocks to Buy
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
Receive News & Ratings for Enveric Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enveric Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.